Understanding Hemophilia A And B Drug Dosage Administration Patterns
Phase of Trial: Phase IV
Latest Information Update: 02 May 2018
At a glance
- Drugs Moroctocog alfa (Primary) ; Nonacog alfa (Primary)
- Indications Haemophilia A; Haemophilia B
- Focus Therapeutic Use
- Sponsors Pfizer
- 05 Apr 2018 Status changed from recruiting to discontinued.
- 05 Mar 2018 Planned number of patients changed from 300 to 200.
- 13 Dec 2017 Status changed from active, no longer recruiting to recruiting.